Suppr超能文献

人类乳腺癌和乳腺良性病变中的端粒酶活性:在临床标本(包括细针穿刺抽吸物)中的诊断应用

Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.

作者信息

Sugino T, Yoshida K, Bolodeoku J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E, Tarin D

机构信息

Nuffield Department of Pathology, University of Oxford, UK.

出版信息

Int J Cancer. 1996 Aug 22;69(4):301-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8.

Abstract

We analysed telomerase activity in normal, benign and malignant breast tissues and in fine needle aspirates by a PCR-based assay. The tissue samples we used in this assay consisted of 20 cryostat sections, 10 microns thick, from each breast biopsy. This method was used to obtain effective extraction from small samples and to confirm the histological identity of the specimen by microscopical examination of serial sections. Fifty-two of 71 breast carcinomas were positive for telomerase activity, and the intensity of this was strong in most cases, whereas all 6 samples of normal breast tissue and 17 of fibrocystic disease were negative and only 1 of 15 fibroadenomas was positive. Invasive ductal carcinomas were more frequently positive than invasive lobular carcinomas. There was no correlation of telomerase activity with tumour size or the occurrence of lymph node metastasis. Evaluation of our assay system showed that a signal of telomerase activity was detectable in extracts from single cryostat sections (< 1 mm2) of a cancer specimen and from as few as 4 cells of a human breast cancer cell line. On the basis of the above data, we applied this assay to fine needle aspirates of breast lesions. Ten of 15 aspirates which had been cytopathologically diagnosed as cancer were strongly positive, while 26 of 29 benign aspirates were totally negative and the remaining 3 showed only borderline activity. In 3 cases, the telomerase result could have helped establish a diagnosis when the cytological observations were inconclusive. Our results indicate that this sensitive assay could become a useful new modality for supplementing microscopic cytopathology in the detection of cancer cells in small tissue biopsies and fine needle aspirates.

摘要

我们通过基于聚合酶链反应(PCR)的检测方法,分析了正常、良性及恶性乳腺组织以及细针穿刺抽吸物中的端粒酶活性。在该检测中,我们使用的组织样本由每次乳腺活检获取的20个厚度为10微米的低温恒温器切片组成。此方法用于从小样本中有效提取物质,并通过对连续切片进行显微镜检查来确认标本的组织学特征。71例乳腺癌中有52例端粒酶活性呈阳性,且在大多数情况下活性强度较强,而所有6例正常乳腺组织样本及17例纤维囊性疾病样本均为阴性,15例纤维腺瘤中仅有1例呈阳性。浸润性导管癌比浸润性小叶癌更常呈阳性。端粒酶活性与肿瘤大小或淋巴结转移的发生无相关性。对我们的检测系统评估显示,在癌标本的单个低温恒温器切片(<1平方毫米)提取物以及人乳腺癌细胞系少至4个细胞的提取物中均可检测到端粒酶活性信号。基于上述数据,我们将该检测应用于乳腺病变的细针穿刺抽吸物。15例经细胞病理学诊断为癌症的抽吸物中有10例呈强阳性,而29例良性抽吸物中有26例完全阴性,其余3例仅显示临界活性。在3例病例中,当细胞学观察结果不明确时,端粒酶检测结果有助于确诊。我们的结果表明,这种灵敏的检测方法可能成为一种有用地新方法,用于在小组织活检和细针穿刺抽吸物中检测癌细胞时补充显微镜下细胞病理学检查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验